DPP8/9 inhibitors, which induce pyroptosis in acute myeloid leukemia, also activate pyroptosis in other cells, such as B cells and CD34+ cells (93) and augment treatment-associated toxicity. Here, DPP8 is linked to acute myeloid leukemia.